FIELD: medicine.
SUBSTANCE: substance of the invention consists in application of 5-[2-ethoxy-5-(4-methyl-1-piperazinyl sulphonyl)-phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7N-pyrazolo[4,3-d]pyrimidine-7-one or its pharmaceutically acceptable salt for oral treatment of erectile in men.
EFFECT: agent is first intended for ingestion by the patient.
1 cl
